← All Moonlake Immunotherapeutics filings

Moonlake Immunotherapeutics Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
MLTX
Moonlake Immunotherapeutics
SCHEDULE: BVF Discloses Increased Stake in MoonLake Immunotherapeutics
BVF entities have increased their beneficial ownership in MoonLake Immunotherapeutics to 19.7% following a recent share offering.
NASDAQ
MLTX
Moonlake Immunotherapeutics
SCHEDULE: BVF Discloses Significant Stake in MoonLake Immunotherapeutics
BVF entities report beneficial ownership of 22.3% of MoonLake Immunotherapeutics' Class A ordinary shares following recent transactions.
NASDAQ
MLTX
Moonlake Immunotherapeutics
SCHEDULE: MoonLake Immunotherapeutics Ownership Update
BVF Partners and affiliates report a revised 27.7% beneficial ownership in MoonLake Immunotherapeutics following an increase in outstanding shares.